SATELLITE SYMPOSIUM
SPONSORED BY
SATURDAY
18
SEPTEMBER
Efanesoctocog alfa (BIVV001): Exploring Normalised Haemostasis in Haemophilia
Chairs: Jan Astermark (Sweden)
14:00
Welcome and Introduction
Jan Astermark (Sweden)
14:10
Navigating Uncertainty: Remaining Challenges in Haemophilia Care Today
Katharina Holstein (Germany)
14:25
Efanesoctocog alfa (BIVV001): a new Class of Factor Replacement Therapy
Annemieke Willemze (Sanofi Genzyme)
14:35
The Path to Normalisation in Haemophilia
Elena Santagostino (SobiTM)
14:50
Questions & Answers
Jan Astermark (Sweden)